Underutilization of Aldosterone Antagonists in Heart Failure

Background: Treatment with an aldosterone antagonist (AA) has been shown in multiple trials to reduce heart failure (HF)–related morbidity, mortality, and hospital readmission. American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) treatment guidelines recommend the us...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hosp Pharm
Autors principals: Patterson, Shanise J., Reaves, Anne B., Tolley, Elizabeth A., Ulrich, Dagny, Hilty, Christopher, Clarke, Catherine J., Self, Timothy H.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735744/
https://ncbi.nlm.nih.gov/pubmed/29276242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717724886
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars